Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy

Nadia Mensali; Marit Renée Myhre; Pierre Dillard; Sylvie Pollmann; Gustav Gaudernack; Gunnar Kvalheim; Sébastien Wälchli; Else Marit Inderberg

doi:10.1007/s00262-019-02409-6

Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy

Cancer Immunol Immunother. 2020 Jan;69(1):159-161. doi: 10.1007/s00262-019-02409-6.

Authors

Nadia Mensali^#¹, Marit Renée Myhre^#¹, Pierre Dillard¹, Sylvie Pollmann¹, Gustav Gaudernack^{2

3}, Gunnar Kvalheim¹, Sébastien Wälchli⁴, Else Marit Inderberg⁵

Affiliations

¹ Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway.
² Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway.
³ Faculty of Medicine, University of Oslo, 0316, Oslo, Norway.
⁴ Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway. sebastw@rr-research.no.
⁵ Department of Cellular Therapy, Department of Oncology, Oslo University Hospital, The Norwegian Radium Hospital, 0379, Oslo, Norway. elsmar@rr-research.no.

^# Contributed equally.

Abstract

The original version of this article unfortunately included a mistake in Fig. 2b where the images of mice in the tumour control group (right), day 30 (bottom) should be removed as the wrong images (duplicate of day 17) were inserted by mistake. At this time point the tumour control mice were no longer alive and the images were replaced by black areas.

Publication types

Published Erratum